Abstract
Haemophilia A is a congenital disorder of coagulation that mainly affects males and causes a considerable use of resources, especially when hemophilic patients are treated with prophylaxis. The aim of the present review was to discuss and appraise the methodological aspects and results of published economic evaluations of haemophilia A treatments in the last decade.
Original language | English |
---|---|
Pages (from-to) | 596164-596164 |
Number of pages | 9 |
Journal | The Scientific World Journal |
Volume | 2015 |
DOIs | |
Publication status | Published - 2015 |
Keywords
- pharmacoeconomic review